Among them, three distinct sarcoma subtypes with specific clinical, pathological, and molecular features have been individualized in the last WHO classification, including CIC‐rearranged sarcoma (CIC‐RS), BCOR‐rearranged sarcoma, and SRBCS with EWSR1‐non ETS fusion.2 This evidence concerns the gene EWSR1 and sarcoma.